KOR

e-Article

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’
Document Type
Article
Source
In European Journal of Cancer May 2018 94:95-103
Subject
Language
ISSN
0959-8049